Efficacy News and Research

RSS

New influenza vaccine strategies aim to enhance protection with T-cell responses

A recent review highlights the need for innovative influenza vaccines that combine T-cell and antibody responses to enhance protection across multiple strains and seasons.

6 May 2024

Wild Sumatran orangutan uses medicinal plant to treat facial wound

Researchers documented the first observed case of a wild Sumatran orangutan actively treating a wound using a medicinal plant, offering insights into the origins of self-medication in non-human species.

5 May 2024

New study shows age, sex, race crucial for predicting mortality risks in older adults

Study finds that the LS7 and LE8 scores predict all-cause and cardiovascular mortality with similar efficacy in the overall U.S. population. However, the PCE score is better at predicting mortality in individuals aged 40 to 79.

5 May 2024

NK cells' role in cancer therapy resistance unveiled

Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune system.

3 May 2024

Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment

...

From Gyros Protein Technologies AB 3 May 2024

Long-term impact of online school-based mental health and substance abuse program: A 72-month study in Australia

The long-term effectiveness of four school-based, online interventions for preventing mental health and substance use.

3 May 2024

Study reveals how photobiomodulation improves cognitive alterations from chronic stress

Some neurological disorders can be improved through photobiomodulation, a non-invasive technique based on the application of low-intensity light to stimulate altered functions in specific regions of the body.

2 May 2024

New discovery offers dietary solution for pulmonary hypertension

Blood vessels in the lungs aren't like the others in the body. This difference becomes clear in pulmonary hypertension, in which only the lungs' blood vessels stiffen progressively, leading to chronic lung disease, heart failure and death.

2 May 2024

Glycoengineered stem cells enhance brain recovery after cardiac arrest, study finds

Researchers at the University of Maryland School of Medicine have identified an innovation in stem cell therapy to regenerate neural cells in the brain after cardiac arrest in an animal model.

2 May 2024

High testosterone levels in older men associated with greater risk of atrial fibrillation

Researchers investigated whether higher endogenous testosterone levels increase atrial fibrillation (AF) risk among healthy older males.

2 May 2024

ELRIG UK announces Profs Ijeoma Uchegbu and Marcus Schindler as keynote speakers at Drug Discovery 2024

Drug Discovery 2024: Connecting Minds, Transforming Science, Empowering Community will take place at ExCeL London from 2–3 October.

From ELRIG (UK) Ltd. 2 May 2024

Psilocybin found to be more effective than controls for treating depression symptoms

Psilocybin - the active ingredient in "magic" mushrooms - is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, suggests a study published by The BMJ today.

1 May 2024

New monoclonal antibody vaccine slashes malaria risk in children

A recent study demonstrates that the monoclonal antibody-based vaccine L9LS is safe for children aged 6 to 10 and significantly reduces the risk of malaria infection and clinical symptoms by 70% and 77%, respectively.

30 Apr 2024

UNIGE's synthetic anticoagulant provides reliable alternative to heparin

Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis.

30 Apr 2024

STRONG STAR Consortium awarded $17M for traumatic brain injury and psychological health research

In a recent round of grant awards, the STRONG STAR Consortium based at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was selected by the U.S. Department of Defense for a total of $17 million in funding to launch eight new research projects focused on traumatic brain injury and psychological health.

29 Apr 2024

Georgetown study raises concerns over aspirin's role in breast cancer treatment

A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University's Lombardi Comprehensive Cancer Center.

29 Apr 2024

Genetic associations of key genes in breast cancer pathogenesis

Breast cancer remains a significant global health concern, warranting further exploration into its genetic basis and potential therapeutic targets.

29 Apr 2024

Study rethinks immune system strategies to boost vaccine effectiveness

A recent Cell journal review explores key immunological assumptions to enhance our understanding of vaccine design, autoimmune responses, and immune system pathology, aiming to refine intervention strategies and theoretical frameworks in immunology.

28 Apr 2024

PET brain scans could reveal hidden inflammation in patients with multiple sclerosis

A Brigham and Women’s Hospital study of 30 people found that, in patients with MS, advanced brain imaging could identify hidden inflammation not picked up on traditional MRIs

27 Apr 2024

Parkinson’s UK invests £2.1 million in Neumora Therapeutics for preclinical testing of new Parkinson’s drug

Parkinson’s UK is investing £2.1million to support Neumora Therapeutics to carry out preclinical testing of NMRA-NLRP3, a NLRP3 inhibitor with the potential to reduce inflammation and protect brain cells in Parkinson’s. NLRP3 is a protein that plays a role in regulating a number of inflammatory processes that are believed to contribute to the damage to brain cells that underlies Parkinson’s.

27 Apr 2024

1
2
3
4
...
1184
Next

Efficacy News and Research

New influenza vaccine strategies aim to enhance protection with T-cell responses

Wild Sumatran orangutan uses medicinal plant to treat facial wound

New study shows age, sex, race crucial for predicting mortality risks in older adults

NK cells' role in cancer therapy resistance unveiled

Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment

Long-term impact of online school-based mental health and substance abuse program: A 72-month study in Australia

Study reveals how photobiomodulation improves cognitive alterations from chronic stress

New discovery offers dietary solution for pulmonary hypertension

Glycoengineered stem cells enhance brain recovery after cardiac arrest, study finds

High testosterone levels in older men associated with greater risk of atrial fibrillation

ELRIG UK announces Profs Ijeoma Uchegbu and Marcus Schindler as keynote speakers at Drug Discovery 2024

Psilocybin found to be more effective than controls for treating depression symptoms

New monoclonal antibody vaccine slashes malaria risk in children

UNIGE's synthetic anticoagulant provides reliable alternative to heparin

STRONG STAR Consortium awarded $17M for traumatic brain injury and psychological health research

Georgetown study raises concerns over aspirin's role in breast cancer treatment

Genetic associations of key genes in breast cancer pathogenesis

Study rethinks immune system strategies to boost vaccine effectiveness

PET brain scans could reveal hidden inflammation in patients with multiple sclerosis

Parkinson’s UK invests £2.1 million in Neumora Therapeutics for preclinical testing of new Parkinson’s drug

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News